www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Scientific focus
    • Science & technology
    • Pipeline
    • Digital innovation
    • Clinical data sharing
    • Collaboration & partnerships
    • Healthcare Professionals
      • Allergy Immunotherapy
      • Reweal
      • Clinical trials
      • Webinars
      • The Henning Lowenstein Research Award
  • Our company
    • Press
    • Our strategy
    • Our leadership
    • Our history
    • Corporate governance
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Executive Leadership Team
      • Board of Directors
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
      • Capital Markets Day 2024
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
    • Contact IR
    • Annual general meeting
      • Annual general meeting (DK)
    • Capital Markets Day 2024
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

Download library

DocumentType
Annual General Meeting 2019 Minutes
Annual General Meeting 2019 Minutes
Corporate Governance 2018
Corporate Governance 2018
Annual report 2018
Annual report 2018
Statutory Corporate Governance Statement for 2018, cf. art. 107b of the Danish Financial Statements Act
Statutory Corporate Governance Statement for 2018, cf. art. 107b of the Danish Financial Statements Act
Dansk resumé af årsrapport 2018
Dansk resumé af årsrapport 2018
Key figures for 2018
Key figures for 2018
Nine-month interim report (Q3) 2018
Nine-month interim report (Q3) 2018
Six-month interim report (Q2) 2018
Six-month interim report (Q2) 2018
Statutory Corporate Governance Statement for 2017, cf. art 107b of the Danish Financial Statements Act
Statutory Corporate Governance Statement for 2017, cf. art 107b of the Danish Financial Statements Act
Corporate Governance 2017
Corporate Governance 2017

Pagination

First page« firstPrevious page‹ previous
...
Page 4
Page 5
Page 6
Page 7
Current page 8
Page 9
Page 10
Page 11
Page 12
...
Next pagenext ›Last pagelast »
 
  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved